Figure A3 from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

Autor: John H. Sampson, Thomas A. Davis, Tibor Keler, Christopher D. Turner, Michael J. Yellin, Jennifer A. Green, Yi He, Laura Vitale, Scott Cruickshank, Maciej M. Mrugala, J. Paul Duic, Lynn S. Ashby, Rimas V. Lukas, Daniela A. Bota, Gordon Li, Louis B. Nabors, Karen L. Fink, David D. Tran, Donald M. O'Rourke, James J. Vredenburgh, Annick Desjardins, David A. Reardon
Rok vydání: 2023
DOI: 10.1158/1078-0432.22473939
Popis: Figure A3 from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
Databáze: OpenAIRE